Clinical Trial Update: BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY [Phase 2]

View source ↗

Summary

Phase II study investigating liposomal alendronate in diabetes mellitus; current status and results are not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• liposomal alendronate (alendronate liposome)

Snippet

Sponsor: BIOrest Ltd. | Conditions: Diabetes Mellitus | Phase 2 | Status: UNKNOWN